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Abstract
Aim: This review evaluates the possible relationship between periodontal disease and
pre-eclampsia, a major pregnancy complication. A generalized inﬂammatory response
plays an important role in the pathogenesis of pre-eclampsia. Because periodontal
disease is a low-grade inﬂammatory state, periodontal disease might contribute to the
pathogenesis of pre-eclampsia.
Main Findings and Conclusion: A literature search of PubMed, EMBASE and
CINAHL until August 2010 revealed 12 eligible observational studies and three
randomized-controlled trials (RCTs). It appeared difﬁcult to compare these studies,
due to variations in deﬁnitions of periodontal disease and pre-eclampsia, timing of
periodontal examination and inadequate control for confounding factors. Eight
observational studies reported a positive association, while four studies found no
association. None of the RTCs reported reductions in pre-eclamptic rate after
periodontal therapy during pregnancy. Therefore, it is questionable whether
periodontal disease plays a causal role in the pathogenesis of pre-eclampsia. The
observed association in eight observational studies might be the result of induction of
periodontal disease due to the pre-eclamptic state or it may be an epiphenomenon of an
exaggerated inﬂammatory response to pregnancy. Larger RCTs with pre-eclampsia as
the primary outcome and pathophysiological studies are required to explore causality
and to dissect biological mechanisms involved.
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Periodontal disease is a chronic destruc-
tive inﬂammatory disease affecting the
tooth-supporting tissues and is one of the
most prevalent chronic infections in
humans. The disease is caused by dental
plaque, a bioﬁlm in which gram-negative
anaerobic microorganisms dominate.
Plaque-associated periodontal diseases
can be divided into gingivitis and perio-
dontitis. Gingivitis refers to an inﬂam-
matory state of the gums, with no loss
of periodontal attachment ﬁbres or
alveolar bone. In periodontitis, progres-
sive destruction of collagen ﬁbres and
supportive bone structures occurs (Pihl-
strom et al. 2005). Periodontal disease is
initiated by oral microorganisms, but it
is believed that the severity of perio-
dontal breakdown is orchestrated by the
inﬂammatory response of the host
(Offenbacher et al. 2008).
The inﬂammatory response may not
be limited to the periodontal focus. It
has been proposed that daily episodes of
bacteraemia or dissemination of bacter-
ial endotoxins originating from the
periodontal focus may induce systemic
activation of the inﬂammatory response
(Geerts et al. 2002, Loos 2005). Bacteria
or bacterial endotoxins in the systemic
circulation may induce pro-inﬂamma-
tory cytokine production (Scannapieco
2004). These cytokines then further
activate the inﬂammatory response,
resulting in a chronic low-grade sys-
temic up-regulation of inﬂammatory
responses involving IL-6 and C-reactive
protein (CRP) (Loos et al. 2000, Mout-
sopoulos & Madianos 2006, Paraskevas
et al. 2008, Nakajima et al. 2009). It also
includes activation of inﬂammatory
cells and endothelial cells and may
result in endothelial dysfunction (Amar
et al. 2003, Tonetti et al. 2007, Higashi
et al. 2008, Piconi et al. 2008).
In pregnancy, the immune response
plays a pivotal role in maintaining a
healthy equilibrium between mother
and foetal allograft (Aagaard-Tillery
et al. 2006). During normal pregnancy,
not only the speciﬁc immune response is
shifted towards a Th2-type immune
response but also the inﬂammatory
response is activated (Sargent et al.
2006). This activation of the inﬂamma-
tory response during pregnancy is char-
acterized by an increased expression
of activation markers on monocytes
and granulocytes (Sacks et al. 1998),
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1075 r 2010 John Wiley & Sons A/Sdifferences in monocyte cytokine pro-
duction (Veenstra van Nieuwenhoven et
al. 2003), increased circulating levels of
pro-inﬂammatory cytokines (Curry et al.
2008) and inﬂammatory markers, such
as CRP (von Versen-Hoeynck et al.
2009).
It has been suggested that exacerba-
tion of this inﬂammatory response dur-
ing pregnancy may result in pregnancy
complications, e.g. pre-eclampsia (Sar-
gent et al. 2006). Pre-eclampsia is a
maternal multi-organ disease, clinically
manifest in the second half of pregnancy
by the appearance of hypertension and
proteinuria (Walker 2000). It is a dis-
order unique to pregnancy, with a pre-
valence of approximately 2–3% and it is
one of the leading causes of maternal
morbidity and mortality in the western
world (Saftlas et al. 1990). The patho-
genesis is not completely understood,
but it is generally accepted that endothe-
lial dysfunction of the maternal vascular
system plays a key role in the clinical
manifestations of the disease. Pre-
eclampsia is most likely the result of a
generalized inﬂammatory response,
including activation of inﬂammatory
and endothelial cells (Faas & Schuiling
2001, Redman & Sargent 2004, Roberts
& Gammill 2005). As compared with
normal pregnancy, there is an increased
activation of this inﬂammatory response
during pre-eclampsia (Roberts 1998,
Sacks et al. 1998, Donker et al. 2005,
Chavarria et al. 2008, Veenstra van
Nieuwenhoven et al. 2008).
Women with diseases associated with
chronic low-grade inﬂammation, such
as diabetes mellitus, hypertension, obe-
sity and arterial diseases are at an
increased risk of developing pre-
eclampsia (Rodie et al. 2004, Duckitt
& Harrington 2005, Abenhaim et al.
2007). Because periodontal disease is
also associated with low-grade inﬂam-
mation, it can be hypothesized that
patients with periodontal disease have
an increased risk of developing pre-
eclampsia. A number of studies recently
focused on a possible relationship
between periodontal disease and pre-
eclampsia. The aim of this review is to
evaluate the published scientiﬁc evi-
dence for this possible relationship.
Materials and Methods
Search strategy
For this review, a thorough search of the
literature was performed in the compu-
terized databases of MEDLINE via
PubMed (1969 to August 2010),
EMBASE (1974 to August 2010) and
CINAHL (2003 to August 2010). The
search strategy used was a combination
of MeSH terms and free text words and
is summarized in Table 1. The search
was complemented by checking refer-
ences mentioned in relevant review arti-
cles and eligible studies for additional
useful publications with the following
combinations: ‘‘periodontal diseases’’
and ‘‘pregnancy outcomes’’ or ‘‘preg-
nancy complications’’ as well as ‘‘pre-
eclampsia’’ and ‘‘inﬂammation’’ or
‘‘infections’’. The papers were ﬁrst
screened by title and abstract (A. K.).
Full-text papers were obtained when the
studies fulﬁlled the criteria of the study
selection, as described below. Full-text
analysis was performed by two
reviewers (A. K. and J. J. v. D.) inde-
pendently. Case reports, letters, reviews,
abstract-only studies and commentaries
were excluded from the search.
Inclusion criteria
This systematic review included cross-
sectional studies, case–control studies,
prospective and retrospective cohort stu-
dies and clinical trials. No time restric-
tions were implemented with respect to
the year of publication. The additional
inclusion criteria for study selection
were:
 Publications in peer-reviewed jour-
nals on studies in human subjects.
 Papers published in English, French,
German, Dutch and Spanish.
 Comparative studies containing ori-
ginal data that evaluated the obser-
vational association between perio-
dontal disease and pre-eclampsia.
 Clinical trials comparing non-surgi-
cal periodontal treatment versus no
treatment in pregnant women with
periodontal disease regarding the
rate of pre-eclampsia.
Table 1. Search strategy
MEDLINE (via PubMed)
(‘‘Periodontal Diseases’’[MeSH] OR periodont
n OR gingivitis) AND (‘‘Pre-Eclampsia’’[MeSH] OR preeclampsia OR eclampsia OR eclamp
n OR
proteinuria OR ‘‘pregnancy induced hypertension’’ OR gestosis OR EPH OR ‘‘pregnancy toxemia’’ OR (‘‘hypertensive disorders of pregnancy’’)
OR ‘‘gestational pregnancy’’ OR ‘‘pregnancy-associated hypertension’’ OR ‘‘pregnancy hypertension’’)
Limits activated: English, French, German, Spanish, Dutch
Run data search: 15 August 2010
EMBASE
‘‘periodontal disease’’/exp OR ‘‘periodontal disease’’ OR periodont
n OR ‘‘gingivitis’’/exp OR gingivitis AND (‘‘preeclampsia’’/exp OR
preeclampsia OR ‘‘eclampsia’’/exp OR eclampsia OR ‘‘proteinuria’’/exp OR proteinuria OR ‘‘pregnancy induced hypertension’’/exp OR
‘‘pregnancy induced hypertension’’ OR eclamp
n OR ‘‘gestosis’’/exp OR gestosis OR eph OR ‘‘pregnancy toxemia’’/exp OR ‘‘pregnancy toxemia’’
OR ‘‘hypertensive disorders of pregnancy’’ OR ‘‘gestational pregnancy’’ OR ‘‘pregnancy-associated hypertension’’ OR ‘‘pregnancy
hypertension’’/exp OR ‘‘pregnancy hypertension’’) AND ([dutch]/lim OR [english]/lim OR [french]/lim OR [german]/lim OR [spanish]/lim)AND
[embase]/lim
Run data search: 15 August 2010
CINAHL
S1 Search (MH ‘‘Periodontal Diseases1’’)
S2 Search periodont
n OR gingivitis
S3 Search (MH ‘‘Pre-Eclampsia1)
S4 Search preeclampsia OR eclampsia OR proteinuria
OR ‘‘pregnancy induced hypertension’’ OR gestosis OR EPH OR ‘‘pregnancy toxemia’’ OR ‘‘hypertensive disorders of pregnancy’’ OR
‘‘gestational pregnancy’’ OR ‘‘pregnancy-associated hypertension’’ OR eclamp
n OR ‘‘pregnancy hypertension’’
S5 Search (s1 OR s2) AND (s3 OR s4)
Limiters: peer reviewed; exclude MEDLINE records
Run data search: 15 August 2010
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Methodological quality was assessed
using speciﬁc study-design-related check-
lists based on the quality-assessment
forms designed by the Dutch Cochrane
Collaboration (Tables S1–S4). Two
reviewers (A. K. and J. J. v. D.) inde-
pendently generated a score for the
articles included. In case of disagreement,
a consensus was reached by discussion
and if necessary, a third reviewer (F. A.)
was consulted. Case–control studies scor-
ing ﬁve or more plusses (ﬁve out of eight
items of the Cochrane checklist for case–
control studies) were considered to be
methodologically acceptable (den Hartog
et al. 2008) and were included in this
review (Table S1). For the quality assess-
ment of cohort studies, the Dutch
Cochrane checklist for cohort studies
was used. Cohort studies scoring six or
more plusses (six out of nine items of the
Cochrane checklists for cohort studies)
were considered methodologically accep-
table (Table S2). Because there was no
adequate checklist for cross-sectional stu-
diesatthe DucthCochrane Collaboration,
apart from a checklist for diagnostic tests,
a quality-assessment checklist had to be
developed. This checklist was adapted
from the quality checklist used for cohort
studies and included items of checklists
for cross-sectional studies (diagnostic
tests). Cross-sectional studies scoring
ﬁve or more plusses (out of eight items
of this checklist) were included in this
review (Table S3). For clinical trials,
studies scoring six or more plusses [six
out of nine items of the Cochrane check-
lists for randomized-controlled trials
(RCTs)] were considered methodologi-
cally acceptable (Table S4). Information
of the quality assessment on the studies
considered for inclusion is available in
the online version of this article (Tables
S1–S4).
Data extraction and synthesis
For each study, the following data were
independently extracted by the two
observers and recorded in a data sheet:
 Patient selection (patients and con-
trols adequately deﬁned).
 Sample size.
 Selection bias.
 Exposure (periodontal disease).
 Outcome (pre-eclampsia).
 Blinding of investigators (to preg-
nancy outcome).
 Adjustment for well-known con-
founding factors [age, ethnicity, par-
ity, multiple gestation pregnancies,
diabetes mellitus, body mass index
(BMI) or chronic hypertension].
 Reported odds ratios (OR) or risk
ratios (RR) with 95% conﬁdence
interval (CI).
 Follow-up (in case of cohort studies
and clinical trials).
Statistical analysis
Because of the high level of clinical
heterogeneity in periodontal disease
deﬁnitions, it was not possible to apply
statistical methods to estimate overall
pooled risks of periodontal disease from
the selected observational studies. For
the meta-analysis of the RTCs, the sta-
tistical software package ‘‘Stata’’ was
used (STATA 10.0 SE; Stata Corp.,
College Station, TX, USA). Weighted
rates together with random effects models
were used to calculate the overall effects
for the RTCs included. The Cochrane’s Q
test was used to test the homogeneity of
the estimates of OR between studies.
Results
Search results
Following the described search strategy,
we found 331 articles. The reference
lists of these papers and relevant reviews
resulted in two additional papers. The
screening by title and abstract resulted
in 30 eligible articles (Fig. 1). After full-
text reading of these articles, four studies
were excluded because they did not
investigate the association between perio-
dontal disease and pre-eclampsia (Bog-
gess et al. 2006, Vettore et al. 2008,
Michalowicz et al. 2009, Sharma et al.
2009) and also four pathophysiological
studies were excluded (Barak et al. 2007,
Canakci et al. 2007b, Herrera et al. 2007,
Sasahara et al. 2009). Furthermore, one
prospective study (Riche et al. 2002) was
excluded because the identical study
population had been used in a more
recent study (Boggess et al. 2003) and
two more studies (Ruma et al. 2008,
Horton et al. 2010) that performed sec-
ondary analyses of the same population.
One case–control study (Cota et al. 2006)
was excluded because the population had
been added to the sample of a later study
(Siqueira et al. 2008). A total of 18
studies fulﬁlled the inclusion and exclu-
sion criteria and were assessed methodo-
logically.
Assessment of quality
Two observational studies (Oettinger-
Barak et al. 2005, Meurman et al.
2006) were excluded from further ana-
Excluded articles  n=268
- Non-topic related 
- Review 
- Commentary 
- No authors listed 
- Brief item/pictorial 
- Abstract 
- In process 
Identified articles
- MEDLINE (PubMed) search       n=67 
- EMBASE search                          n=256 
- CINAHL search                           n=8 
- HAND search                               n=2
Included for methodological appraisal
n=18 (Table 3+4)
Excluded articles  n=12
- No study on the epidemiological association 
  between periodontal disease and  
  pre-eclampsia 
- Pathophysiological study 
- Multiple publications on the same patients  
Combined (after eliminating
overlapping papers) n=298
Included for full text analysis
n=30
n=237
n=18 
n=7 
n=2 
n=2 
n=1 
n=1 
n=4 
n=4 
n=4 
Included for data analysis
n=15
Excluded articles  n=3
- Oettinger-Barak et al (2005): Characteristics of the 
  study population not clearly defined, exposure not 
  assessed blinded to disease status, confounders not  
  taken into consideration, odds ratios not reported 
- Meurman et al (2006): Characteristics of the study  
  population not clearly defined, high risk on selection  
  bias, confounders not taken into consideration, odds  
  ratios not reported 
- Herrera et al (2009): Patients, therapists and effect  
  examiners not blinded to treatment, groups not  
  comparable at trial entry 
Fig. 1. Flow chart outlining the search strategy and results along the various steps.
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the quality assessment checklist scored
negative (Tables S1–S3). Of the 12
observational studies included for further
data analyses, three studies (Khader et
al. 2006, Siqueira et al. 2008, Lohsoon-
thorn et al. 2009) scored positive for all
assessed items and were considered to
have the highest level of quality with an
estimated low risk of bias. Selection
bias could not be excluded in six studies
(Castaldi et al. 2006, Contreras et al.
2006, Canakci et al. 2007a, Kunnen
et al. 2007, Srinivas et al. 2009, Shetty
et al. 2010). Of these, one study also
provided insufﬁcient information about
study group characteristics (Castaldi et
al. 2006). Selective loss-to-follow-up
could not be excluded in two of the
cohort studies (Boggess et al. 2003,
Srinivas et al. 2009). Blinding to out-
come has not been reported in four
studies (Boggess et al. 2003, Contreras
et al. 2006, Kunnen et al. 2007, Shetty
et al. 2010), and has not clearly been
described in two studies (Canakci et al.
2004, 2007a). Two studies (Castaldi et
al. 2006, Contreras et al. 2006) did not
adjust for important confounders with
respect to the analyses. Two studies did
not clearly deﬁne pre-eclampsia (Canak-
ci et al. 2007a, Nabet et al. 2010), while
Shetty et al. (2010) did not clearly
specify the adopted periodontal disease
deﬁnition in their statistical analysis.
One RCT (Herrera et al. 2009) was
excluded from further analyses, because
more than three items of the quality
assessment scored negative (Table S4).
All three RTCs included were largely
comparable in methodological quality.
Clearly, blinding of patients and dental
therapists to treatment was impossible,
because treatment consisted of manual
periodontal therapy. Two studies
(Michalowicz et al. 2006, Offenbacher
et al. 2009) did not clearly specify
whether staff members who included
patients were blinded to the randomiza-
tion order.
A total of 15 articles fulﬁlled the
inclusion criteria and passed the quality
assessment. All studies appeared to be
published in peer-reviewed journals
between January 2003 and August
2010. Below, each study is described
and summarized in Tables 2 and 3.
Cross-sectional studies
Castaldi et al. (2006) examined the
periodontal condition of 1562 women
within 48h after delivery. Of the total
population included, 157 (10%) women
were diagnosed with pre-eclampsia. The
periodontal investigators were blinded
for pregnancy outcomes. Gingivitis was
found in 34.3% and severe periodontal
disease in 17.5% of the women. After
adjusting for smoking during pregnancy,
no association was found between either
gingivitis or severe periodontal disease
and pre-eclampsia. The authors did not
report to have adjusted for other con-
founding factors.
Case–control studies
In a matched case–control study, Canak-
ci et al. (2004) examined within 48h
before delivery, the periodontal condi-
tion of 41 pre-eclamptic women and 41
normotensive healthy pregnant women.
Cases and controls were individually
matched for age, parity, gravidity,
smoking and prenatal care. Periodontal
disease was present in 46.3% of women
with pre-eclampsia and in 21.9% of
controls. After adjusting for serum cho-
lesterol levels, serum triglycerides
levels and maternal body weight, the
conditional multiple logistic regression
analysis showed that pre-eclampsia was
associated with periodontal disease.
Contreras et al. (2006) carried out a
case–control study that included 130
pregnant women with pre-eclampsia
and 243 healthy pregnant women. In
both groups, the periodontal status was
determined between 26 and 36 weeks of
pregnancy. Chronic periodontal disease
was signiﬁcantly more prevalent in the
pre-eclamptic group (63.8%) compared
with the control group (36.6%). When
periodontal disease was further stratiﬁed
in severity, incipient periodontal
destruction was present in 42.3% of
cases, compared with 27.2% of controls,
whereas moderate-to-severe periodontal
destruction was observed in 21.5% of
cases, compared with 9.5% of controls.
The authors did not report to have
adjusted for confounding factors.
Khader et al. (2006) conducted a
blinded case–control study among 115
pre-eclamptic women and 230 healthy
controls within 24h after delivery. Only
insured, non-smoking and non-alcohol
drinking women were included in this
study. After confounding for maternal
age, parity, family history of pre-
eclampsia, family history of cardiovas-
cular disease, pre-pregnancy BMI, twin
birth and self-reported emotional stress
during pregnancy, no statistical differ-
ences were found between cases and
controls concerning any of the eight
periodontal parameters investigated.
The association between periodontal
disease and early-onset pre-eclampsia
(o34 weeks of pregnancy) was tested
in a case–control study conducted by
our own group (Kunnen et al. 2007).
The periodontal condition of 17 early-
onset pre-eclamptic women and 35
women with uncomplicated pregnancies
was examined in a period of 3–28
months postpartum. Severe periodontal
disease was present in 82% of the post-
pre-eclamptic women and in 37% of the
controls. After adjusting for age, BMI,
smoking and educational level, severe
periodontal disease was associated with
pre-eclampsia.
The aim of a case–control study per-
formed by Canakci et al. (2007a) was to
correlate the severity of periodontal
disease to the severity of pre-eclampsia.
Dental and periodontal examinations
were performed in 20 mild pre-eclamp-
tic, 18 severe pre-eclamptic and 21
healthy pregnant women within 48h
preceding delivery. Mild periodontal
disease was found in 16.7% of the
severe pre-eclamptic women, in 25%
of the mild pre-eclamptic women and
in 28.6% of the controls. Severe perio-
dontal disease was detected in 72.2% of
the severe pre-eclamptic women, in
50% of the mild pre-eclamptic women
and in 33.3% of the controls. After
adjusting for age, smoking, body
weight, socioeconomic status and edu-
cational level, the results showed that
severe periodontal disease was asso-
ciated with both mild and severe pre-
eclampsia.
Siqueira et al. (2008) performed a
matched case–control study on 125 pre-
eclamptic women and 375 healthy con-
trols within 48h after delivery. The fre-
quency of periodontal disease before
matching was signiﬁcantly higher among
the pre-eclamptic women (56.7%) than
among the control group (39%). After
matching and adjusting for maternal age
X30 years, chronic hypertension, primi-
parity, previous pre-term birth and pre-
natal visits, periodontal disease remained
associated with pre-eclampsia. However,
when periodontal probing depth (PPD)
and clinical attachment level (CAL) were
tested with cut-off points of X5o r
X7mm, the ORs for pre-eclampsia
were not signiﬁcant, indicating that perio-
dontal breakdown in itself was not asso-
ciated with pre-eclampsia in this study.
A recent epidemiological study was
conducted by Lohsoonthorn et al.
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r 2010 John Wiley & Sons A/S(2009), who examined the periodontal
condition of 150 pre-eclamptic and 150
healthy controls within 48h after deliv-
ery. In the pre-eclamptic group, 49.3%
of the women had mild periodontitis,
21.3% had moderate periodontitis and
severe periodontitis was present in 8.0%
of the women. In the control group,
54.0% of the women were diagnosed
with mild periodontitis, while moderate
periodontitis was present in 20.7% and
severe periodontitis in 4.7% of the
women. After adjusting for maternal
age, educational attainment, parity,
pre-pregnancy BMI, annual household
income, employment during pregnancy,
marital status, onset of pre-natal care,
alcohol use and smoking during preg-
nancy, no association between perio-
dontal disease and pre-eclampsia was
found. In addition to their periodontal
disease deﬁnition (Albandar 2007),
the authors evaluated whether the
previously found associations between
periodontal disease and pre-eclampsia
were due to differences in adopted
periodontal disease deﬁnitions. There-
fore, they used deﬁnitions used by
Canakci et al. (2004), Contreras et al.
(2006), Lopez et al. (2002) and Boggess
et al. (2003) on their dataset. In this Thai
population, none of the deﬁnitions used
by the other authors showed a signiﬁ-
cant association between periodontal
disease and pre-eclampsia.
In a study conducted by Nabet et al.
(2010), the association between perio-
dontitis and pre-term delivery ( o37
weeks of gestation) was analysed
according to the causes of pre-term
birth. For this purpose, 1108 cases with
pre-term delivery (liveborn child
between 22 and 36 weeks of gestation)
and 1094 controls with deliveries at
term (X37 weeks of gestation) were
included in the study. One hundred and
ninety-eight (18.1%) of the cases were
induced pre-term deliveries due to pre-
eclampsia. Periodontal examinations
were performed within 2–4 days after
delivery. Localized periodontitis was
found in 13.6% of the cases and in
10.8% of the controls, while generalized
periodontitis was present in 20.7% of
the cases and in 10.8% of the controls.
After adjusting for maternal age, parity,
nationality, educational level, marital
status, employment during pregnancy,
BMI before pregnancy and smoking
status, an association was observed
between generalized periodontitis and
induced pre-term birth due to pre-
eclampsia.
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control study so far was conducted by
Shetty et al. (2010), who examined the
periodontal condition of 30 pre-eclamp-
tic women and 100 healthy pregnant
controls at recruitment (26–32 weeks
of gestation) and within 48h after deliv-
ery. At enrolment, 100% of the cases
and 78% of the controls were diagnosed
with periodontal disease (CALX3mm).
After adjusting for maternal age,
body weight, occupation, education
and income, severe periodontal disease
(CAL45mm) both at enrolment as well
as at delivery was associated with an
increased risk of pre-eclampsia. There
were no signiﬁcant differences in dis-
ease progression between cases and
controls.
Cohort studies
As part of a prospective cohort study on
the effect of maternal periodontal
disease on obstetric outcomes [the
Oral Conditions and Pregnancy Study
(OCAP)] (Riche et al. 2002), Boggess
et al. (2003) examined the periodontal
condition of 850 pregnant women at
enrolment (before 26 weeks’ gestation)
and followed them until delivery.
Thirty-nine women (4.6%) developed
pre-eclampsia. At enrolment, 58.4% of
the women were diagnosed with mild
periodontitis and 14.7% had severe dis-
ease. In order to determine periodontal
disease progression, a second perio-
dontal examination was performed in
763 of the women within 48h after
delivery. At this time, 37.3% of the
women had mild periodontal disease
and 13.1% had severe periodontal dis-
ease. Periodontal disease progression
occurred in 26.6% of the women. After
adjusting for maternal age, race, insur-
ance status, delivery at o37 weeks’
gestation and smoking during preg-
nancy, the authors found that women
were at a higher risk of developing pre-
eclampsia if they had severe periodontal
disease at delivery or periodontal dis-
ease progression during pregnancy.
Periodontal disease at enrolment, how-
ever, was not associated with an increased
risk of developing pre-eclampsia.
As part of a large multi-centre pro-
spective cohort study (the Periodontal
Infection and Prematurity Study, PIPS),
the risk of adverse pregnancy outcomes
in women with periodontal disease com-
pared with those without disease was
assessed by Srinivas et al. (2009). In this
study, 311 pregnant women with perio-
dontal disease between 6 and 20 weeks
of gestation and 475 without periodontal
disease were included. Periodontal
examinations were performed by trained
nurses. Sixteen women (5.2%) with
periodontal disease developed pre-
eclampsia, while in the periodontally
healthy group 32 women (6.7%) devel-
oped pre-eclampsia. After adjusting for
maternal age, race, tobacco, obesity and
chronic hypertension, the authors found
no association between the presence of
periodontal disease during pregnancy
and pre-eclampsia.
RCTs
In an intervention study conducted by
Michalowicz et al. (2006), the effect of
periodontal treatment on pregnancy out-
comes was examined. Eight hundred
and twelve pregnant women with perio-
dontal disease were randomly assigned
to two groups between 13 and 17 weeks
of gestation. Periodontal disease was
assessed at trial entry, at 21–24 weeks’
gestation and at 29–32 weeks’ gestation.
The treatment group received periodontal
therapy before 21 weeks of gestation,
which consisted of up to four sessions
of scaling and root planing (SRP). Treat-
ment participants also received monthly
tooth polishing, oral hygiene instruction
and if needed, SRP was provided to the
treatment group until delivery. The con-
trol group received only a brief examina-
tion at monthly follow-ups and received
periodontal treatment after delivery.
Although the primary outcome of this
study was gestational age at the end of
pregnancy (pre-term birth), the authors
also evaluated pre-eclampsia as one of
the secondary outcomes. Periodontal
treatment during pregnancy did not sig-
niﬁcantly alter the rate of pre-eclampsia,
despite the improvement of the perio-
dontal status.
Offenbacher et al. (2009) also studied
the effects of periodontal treatment on
the frequency of pre-term birth as the
primary outcome and pre-eclampsia as
one of the secondary outcomes, in a
randomized treated-masked controlled
trial [The Maternal Oral Therapy to
Reduce Obstetric Risk Study (MOTOR)].
One thousand seven hundred and sixty
eligible pregnant women with at least 20
teeth present and diagnosed with perio-
dontal disease were randomly assigned
to receive periodontal treatment either
before 236
7 weeks of gestation (treatment
group) or after delivery (control group).
Periodontal examinations were per-
formed at baseline and at delivery.
Periodontal treatment included up to
four sessions of SRP, full-mouth tooth
polishing and oral hygiene instruction.
There were no signiﬁcant differences in
the frequency of pre-eclamptic pregnan-
cies when comparing the women in the
treatment group with those in the control
group.
Newnham et al. (2009) investigated
whether periodontal treatment pre-
vented major pregnancy complications,
with pre-term birth as the primary
outcome, and low birth weight and
pre-eclampsia as secondary outcomes.
For this purpose, 1078 pregnant women
were allocated at random to receive
periodontal treatment at  20 weeks
of gestation (treatment group) or after
delivery (control group). Periodontal
examinations were performed at trial
entry (between 12 and 20 weeks gesta-
tion). Periodontal treatment included up
to three sessions of SRP, removing of
overhanging restorations and compre-
hensive oral hygiene instructions.
Patients were advised to additionally
rinse with 0.12% chlorhexidin. At gesta-
tional week 28, further examinations
were performed and a 3-week follow-
up periodontal treatment was offered to
the treatment group if necessary, and
monthly motivation and oral hygiene
instruction was provided. Periodontal
examinations were repeated at 32 and
36 weeks’ gestation. Although perio-
dontal treatment during pregnancy sig-
niﬁcantly improved the periodontal
status, it did not affect the rate of pre-
eclamptic pregnancies.
Meta-analysis of RCTs
After combining the data from the
RTCs, the pooled RR of pre-eclampsia
was 1.0 (95% CI 0.78–1.28) (Fig. 2).
Statistical heterogeneity is Cochrane’s
Q53.24 (df52, p50.198).
Discussion
The present review summarizes the
results of observational studies and
RTCs investigating the relationship
between periodontal disease and pre-
eclampsia. It shows that an association
between periodontal disease and
pre-eclampsia was seen in eight obser-
vational studies, while four of the obser-
vational studies failed to ﬁnd such an
association. None of the RTCs showed a
reduction in pre-eclamptic pregnancies
1082 Kunnen et al.
r 2010 John Wiley & Sons A/Safter periodontal treatment during
pregnancy.
The reasons for the heterogeneity in
ﬁndings among the observational stu-
dies cannot precisely be determined,
because several methodological differ-
ences may have biased study outcomes.
To be able to assess the methodological
quality of the studies, we used speciﬁc
study-design-related forms based on the
Dutch Cochrane Collaboration check-
lists. Although all studies fulﬁlled the
minimum score of our quality assess-
ment, differences in quality between the
studies may contribute to the heteroge-
neity in results. However, even within
the three case–control studies with the
highest methodological quality (plusses
on all items), no homogeneity was
observed between the results: Khader
et al. (2006) and Lohsoonthorn et al.
(2009) failed to ﬁnd an association,
while Siqueira et al. (2008) reported a
positive association between periodontal
disease and pre-eclampsia. Moreover,
although both cohort studies scored
seven plusses (out of nine items) on
the quality assessment, one cohort study
(Boggess et al. 2003) reported a positive
association, while the other cohort study
(Srinivas et al. 2009) found no associa-
tion between the two diseases. Thus,
the observed heterogeneity cannot be
explained by methodological quality
alone, as there appears to be no relation
between the quality of the studies
included and their results.
One of the pertinent issues is the
potential lack of power calculation, as
only ﬁve out of 12 observational studies
reported to have performed power cal-
culations. This problem can be circum-
vented by performing a meta-analysis.
However, we were not able to do this
due to the methodological differences
among the observational studies, which
is the most obvious limitation of this
review. One other important limita-
tion of this review is the variety in
clinical disease deﬁnitions for perio-
dontal disease. At least nine different
periodontal disease deﬁnitions were
adopted throughout the 15 studies
reviewed. Because the strength of the
association between periodontal disease
and pregnancy outcomes may depend
upon the periodontal disease deﬁnition
(Manau et al. 2008), it is difﬁcult to
compare study outcomes.
Moreover, although commonly accep-
ted periodontal deﬁnitions take mean PPD
and CAL (or speciﬁc cut-off points for
PPD and CAL) as a means to classify
periodontitis, PPD and CAL are linear
measures that do not necessarily reﬂect
active periodontal disease and do not
quantify the total inﬂammatory burden
(Nesse et al. 2008). In order to estimate
active periodontal disease, also bleeding
on probing (BOP) should be included in
the periodontal assessment. It is impor-
tant to observe that all studies that
included BOP in their periodontal dis-
ease deﬁnition found an association
between periodontal disease and pre-
eclampsia (Boggess et al. 2003, Canakci
et al. 2004, 2007a, Contreras et al. 2006,
Kunnen et al. 2007). In contrast, four out
of seven studies that did not include
BOP in their deﬁnition failed to ﬁnd
an association (Castaldi et al. 2006,
Khader et al. 2006, Lohsoonthorn et al.
2009, Srinivas et al. 2009). Therefore,
the adopted criteria for deﬁning perio-
dontal disease in the studies reviewed
may not provide the proper tool to draw
a decisive conclusion on periodontitis as
a risk factor for pre-eclampsia. Further-
more, eight of the observational studies
excluded third molar periodontal pathol-
ogy from the analysis (Canakci et al.
2004, 2007a, Khader et al. 2006, Kun-
nen et al. 2007, Siqueira et al. 2008,
Lohsoonthorn et al. 2009, Nabet et al.
2010, Shetty et al. 2010). It is possible
that the exclusion of third molar pathol-
ogy, which has recently been associated
with pre-term birth (Moss et al. 2007)
has led to an underestimation of perio-
dontal disease and therefore may have
biased study outcomes.
Periodontal disease as well as pre-
eclampsia are of a multi-factorial nature,
and both diseases share some common
risk factors, like ethnicity (Mostello
et al. 2002, Borrell & Crawford 2008).
Although periodontal disease was asso-
ciated with pre-eclampsia in certain
populations (i.e. Turkish, Dutch and
Indian) (Canakci et al. 2004, Kunnen
et al. 2007, Shetty et al. 2010), it was not
in others (Khader et al. 2006, Lohsoon-
thorn et al. 2009), irrespective of the
adopted periodontal disease deﬁnition.
Thus, in certain ethnic populations,
other factors, e.g. genetically deter-
mined host responses, might be invol-
ved. Some of the studies did not clearly
report the ethnicity of their populations
(Castaldi et al. 2006, Canakci et al.
2007a, Nabet et al. 2010), or included
heterogeneous populations (Boggess
et al. 2003, Contreras et al. 2006,
Siqueira et al. 2008, Srinivas et al.
2009).
Also, smoking and obesity may inﬂu-
ence the severity of both conditions
(O’Brien et al. 2003, Genco et al.
2005, Leddy et al. 2008, Boesing et al.
2009, Haffajee & Socransky 2009).
Smoking increases the risk of perio-
dontal disease (Bergstrom 2004), but
paradoxically decreases the risk of pre-
eclampsia (Conde-Agudelo et al. 1999,
Hammoud et al. 2005, Engel et al.
2009). Although most studies reported
to have controlled for smoking or
Fig. 2. Fixed effect analysis of the meta-analyses of randomized-controlled trials.
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smoking behaviour was only reported
dichotomously (yes/no). Therefore,
smoking behaviour may have had
some residual confounding effects on
the strength of the association. Further-
more, three of the studies did not report
or adjust for BMI in their analyses
(Castaldi et al. 2006, Contreras et al.
2006, Siqueira et al. 2008).
All observational studies met the
minimum criteria for deﬁning pre-
eclampsia (National High Blood Pres-
sure Education Program Working Group
on High Blood Pressure in Pregnancy
2000). However, a distinction can be
made between early-onset pre-eclamp-
sia (gestational age o34 weeks) and
late-onset pre-eclampsia (gestational
age 434 weeks) (von Dadelszen et al.
2003, Redman & Sargent 2005). The
two forms differ in pathogenesis, genet-
ic risk and inheritance (von Dadelszen
et al. 2003, Duckitt & Harrington 2005).
Indeed, in the study of Shetty et al.
(2010), a remarkably high incidence of
periodontal disease was observed in
early-onset pre-eclamptic women. This
could indicate that an association
between periodontal disease and pre-
eclampsia may only be evident in cer-
tain forms of pre-eclampsia. Concerning
the RTCs, none of the studies reported a
clear deﬁnition for pre-eclampsia.
Because Offenbacher et al. (2009) per-
formed therapy up to 24 weeks’ gesta-
tion, it cannot be excluded that some of
the women assigned to the treatment
group already developed early-onset
pre-eclampsia before intervention. This
may have biased study outcomes.
Inconsistent ﬁndings in the observa-
tional studies may also be due to differ-
ences in the time points of the
periodontal screening. The periodontal
disease status was examined at different
time points during pregnancy or post-
partum, ranging from before 26 weeks
of gestation to 3–28 months postpartum.
The long-time span between outcome
and exposure in the study of Kunnen
et al. (2007) may have allowed for
changes in the periodontal condition.
Moreover, one may argue that in this
study, pre-eclampsia was the exposure
and the periodontal status the outcome.
Therefore, this study may suggest that
pre-eclampsia induced periodontal dis-
ease rather than that periodontal disease
induced pre-eclampsia. Also, the timing
of periodontal treatment may not have
been optimal. The clinical symptoms of
pre-eclampsia are thought to be late
manifestations of pathological processes
in the ﬁrst half of pregnancy (Redman &
Sargent 2005, Roberts & Gammill
2005). Therefore, periodontal therapy
at  20 weeks of gestation may be too
late in pregnancy to prevent pre-eclamp-
sia. Moreover, translocation of micro-
organisms from the periodontal infec-
tion to the placental tissues may have
occurred before therapy.
Although the present review does not
undisputedly show that periodontal
disease induces pre-eclampsia; there
are various indications that periodontal
disease may play a role in the pathogen-
esis of pre-eclampsia. Key pathogens
associated with periodontal disease in
adult subjects are the gram-negative
microorganisms Aggregatibacter acti-
nomycetemcomitans, Porphyromonas
gingivalis, Prevotella intermedia, Tan-
nerella forsythia, Fusobacterium nucle-
atum and the gram-positive Parvimonas
micra (van Winkelhoff et al. 2002).
Some studies found a higher prevalence
of P. gingivalis, Eikenella corrodens
and T. forsythia (Contreras et al. 2006,
Herrera et al. 2007) or P. micra (Kunnen
et al. 2007) in subgingival plaque sam-
ples of pre-eclamptic women as com-
pared with healthy pregnant controls.
These bacteria produce a variety of
pro-inﬂammatory factors, e.g. lipopoly-
saccharide (LPS) (O’Brien-Simpson
et al. 2004, Holt & Ebersole 2005,
Bodet et al. 2006, Tanabe et al. 2007),
which may further activate the normal
inﬂammatory response during preg-
nancy, ultimately resulting in pre-
eclampsia. Indeed, infusion of low doses
of Escherichia coli LPS into pregnant
rats leads to the activation of inﬂamma-
tory response and subsequently to a pre-
eclampsia-like syndrome (Faas et al.
1994). Whether LPS of gram-negative
oral pathogens is also capable of pro-
voking pre-eclampsia-like symptoms is
under investigation. Also, the bacteria
themselves may also enter the circula-
tion and affect the inﬂammatory
response or tissues directly. Barak et
al. (2007) found increased bacterial
counts for all important periodontal
pathogens in placentas of women with
pre-eclampsia. The presence of perio-
dontal pathogens in placental tissues of
pre-eclamptic pregnancies may imply a
role for these bacteria in the pathogen-
esis of pre-eclampsia.
Interestingly, prospective studies that
performed periodontal examinations
before 26 weeks of gestation failed to
ﬁnd an association (Boggess et al. 2003,
Srinivas et al. 2009). In fact, although
Boggess et al. (2003) reported that perio-
dontal disease at delivery or periodontal
disease progression during pregnancy
was associated with pre-eclampsia, perio-
dontal disease at enrolment (gestational
age o26 weeks) was not associated
with an increased risk of developing
pre-eclampsia. This may suggest that
periodontal disease does not induce pre-
eclampsia. Although these studies were
not designed to demonstrate that pre-
eclampsia is a risk factor for the induction
of periodontal disease, the possibility
cannot be ruled out that the pre-eclamptic
state itself may have induced or aggra-
vated periodontal problems, as was sug-
gested above for the study of Kunnen et
al. (2007). This is in line with the two-hit
model of Golub et al. (2006). In this
model, the ﬁrst hit is initiated by detri-
mental microbial products arising from
the periodontal bioﬁlm. The second
hit is the generalized inﬂammatory dis-
ease (in this case pre-eclampsia) with
increased circulating levels of pro-inﬂam-
matory cytokines. Together, these two
hits could lead to an increase of local
inﬂammatory mediators and effector
molecules including matrix metallopro-
teinases, and ﬁnally to periodontal break-
down.
The present review shows that in
order to further evaluate the relationship
between periodontal disease and pre-
eclampsia, there is a great need for
larger studies, with standardized proto-
cols. It is especially important to use a
universal standardized periodontal dis-
ease deﬁnition that includes the inﬂam-
matory burden and assesses the risk of
systemic effects of periodontitis. Inter-
estingly, such a model has recently been
developed by Nesse et al. (2008): the
PISA method (periodontal infected sur-
face area). This model calculates the
extensiveness of the infected perio-
dontal surface in square millimetres
and can therefore quantify the total
inﬂammatory burden. Also, RCTs
should be performed that have pre-
eclampsia as primary outcome. More-
over, it is recommended that future
studies focus on dissecting the biologi-
cal mechanisms that may link both con-
ditions. Additional studies in terms of
virulence properties of oral pathogens
and subsequent host responses to these
pathogens during pregnancy as well as
pathophysiological studies investigating
foetal exposure to periodontal microbio-
ta and maternal immune responses are
warranted. Because there is convincing
1084 Kunnen et al.
r 2010 John Wiley & Sons A/Sevidence in non-pregnant individuals
that systemic antibiotics improves perio-
dontal health and has a long-term redu-
cing effect on the bacterial infection
(Lopez et al. 2006), future research on
the effects of periodontal therapy during
pregnancy may include the prescription
of antibiotics.
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Clinical Relevance
Scientiﬁc rationale for the study:
Periodontal disease has been pro-
posed to contribute to the pathogen-
esis of pre-eclampsia. Therefore, we
reviewed the scientiﬁc evidence of
the relationship between periodontal
disease and pre-eclampsia.
Principal ﬁndings: There are indica-
tions of an association between
periodontal disease and some forms
of pre-eclampsia. This is most
obvious in early-onset pre-eclampsia.
However, it is unclear whether perio-
dontal disease plays a causal role in
pre-eclampsia, for this review not
only shows that periodontal therapy
performed at about 20 weeks of
gestation did not reduce pre-eclamp-
tic rates but also studies focusing on
the periodontal condition at enrol-
ment, i.e. before pre-eclampsia had
occurred, failed to show an associa-
tion. Therefore, periodontal disease
at delivery may be the consequence
of the pre-eclamptic state rather than
vice versa. Inconsistent ﬁndings
among the observational studies
may be due to a large variety in
periodontal disease deﬁnitions and
timing of screening.
Practical implications: Periodontal
treatment during pregnancy did not
seem to inﬂuence the risk of pre-
eclampsia. Larger RCTs with stan-
dardized protocols and pre-eclampsia
as the primary outcome as well as
pathophysiological studies are
required to determine whether the
observed relationship between pre-
eclampsia and periodontal disease
in some studies is causal or simply
associative. So far, periodontal treat-
ment during pregnancy, if needed, is
not contraindicated.
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